MedTrace Logo

Detecting Liver Fibrosis in Patients At-risk

NCT07775638 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2026-08-20

No results posted yet for this study

Summary

The project will establish a research cohort (called STELIR; STEatotisk Liver-risk In Rogaland) based on a biobank with an associated health register. The purpose is to collect, store and analyze biological material and clinical data from people at risk of steatotic liver disease (fatty liver disease). The research cohort will consist of individuals who agree to participate and will be followed over many years with planned examinations/tests at baseline, after 2 years, after 5 years and every 5 years thereafter. The STELIR cohort consists of individuals between 40 and 70 years of age who have one or more of the following risk factors: Obesity, type 2 diabetes or hazardous or harmful alcohol consumption.

The biological material and clinical data collected will be stored and used for research on liver-related disease risk, diagnostics and treatment.

Conditions

  • Fatty Liver
  • NAFLD - Non-Alcoholic Fatty Liver Disease
  • Nash
  • MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
  • Biomarker in Early Diagnosis
  • Liver Disease (Alcoholic or Not)
  • Cirrhoses, Liver

Interventions

OTHER

Routine study procedure

Routine study procedures include: Informed consent, medical history and clinical examination, structured questionnaires (lifestyle, alcohol use, metabolic risk factors), liver elastography, blood sample collection for clinical analyses and biobanking. Assessments are conducted at baseline, after 2 years, after 5 years, and subsequently every 5 years.

Sponsors & Collaborators

  • Helse Stavanger HF

    lead OTHER_GOV

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2070-12-31
Completion
2070-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07775638 on ClinicalTrials.gov